Get addiction help now: (858) 838-4343

get help now

Get addiction help now: (858) 838-4343

get help now

Hepatitis C Committee

Time to read: 4 min

Chair: Dr. P. Kishore, MD, MPH, CMA

(Boston NAMA)

Committee Members

Paul Bowman, CMA 

Cheri Jarvis, CMA 

The HCV Committee was created to empower methadone patients through education and advocacy and to provide support for those that do test positive for Hepatitis C.

What Is Hepatitis C?

  • Hepatitis is an inflammation of the liver. Although in many people the diseased liver is able to repair itself and regain function, it may progress to scarring of the liver and chronic liver disease. Hepatitis can have numerous causes. A common cause is infection with one of the several types of viruses (e.g., hepatitis A, B, or C viruses).
  • Hepatitis C virus (HCV) infection occurs when blood, or other body fluids from an infected person enters the body of an uninfected person. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old. Injection drug use and blood transfusion prior to 1992 are major risk factor for HCV infection. About 3.9 million American have been infected with HCV and 2.7 million have chronic infection. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old.
  • HCV infection is becoming a leading cause of cirrhosis. In addition to genetic factors in the infected person three independent factors are associated with an increased rate of disease progression. These factors include daily alcohol consumption, age at infection of more than 40 years, and male gender. These factors have a greater influence on progression to cirrhosis in HCV infection than the virus itself.

What Should You Do If You Have Hepatitis C?

  • There are several actions all people who have chronic viral hepatitis C should take as general measures. Most important of all is to not drink alcoholic beverages, and if necessary, get into treatment, because alcohol makes liver disease worse. Injection drug users should stop injecting drugs and get into and stay in substance abuse treatment. All individuals with chronic liver disease should be immunized against hepatitis A. Individuals with chronic HCV who are at risk also should be immunized against hepatitis B.

Surviving Hep C Group

This group is a support group with emphasis on Hepatitis C. Everyone is welcome to share their experience’s and stories in this group no matter what your status might be. Everyone is encouraged to share information and educational topics. Hepatitis C can be survived, but we have to empower ourselves with knowlege and be our own treatment advocates.

Come on and join NAMA’s hepatitis group and talk with others who have HCV.

http://groups.yahoo.com/group/SurvivingHepC/

Contact List Manager Cheri Jarvis, CMA

[email protected]

Important Documents

Info Facts

Info Facts are prepared by the HCV Committee and under the direction of Dr. Kishore.

Publications

Similar Posts

  • Late Breaking News

    ByAdmin
    Admin 09/01/2021

    Best Practices: Treatment of Opiate Dependence Conference Update   Physician Training for Use of Buprenorphine   The conference planning committee working with the Center for Substance Abuse Treatment and the American Academy of Addictions Psychiatry will be offering the following 8-hour physician workshop during the Best Practices: Treatment of Opiate Dependence Conference, scheduled for March…

  • Registration for the 2022 CMA Training Course is now open!

    ByAdmin
    Admin 06/20/2022

    The 2022 Certified Medication Assisted Treatment Advocate (CMA) Course will be held as a Pre-Conference Session of the 2022 AATOD Conference on:Sunday, October 30, 20229:00am – 5:00pmHilton Baltimore Inner Harbor401 W. Pratt StreetBaltimore, MD 21201We encourage all supporters of MAT, patient and non-patient, to become Certified MAT Advocates so that all energies directed toward the…

  • LAAM Warning

    ByAdmin
    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Letter

    ByAdmin
    Admin 08/13/2021

    Letter, November 9, 2004 Sheriff Chris Curry; Sir, I have read the articles that state you are adiment against having a methadone treatment center in your county. May I point out sir that as a law enforcement officer this could do nothing but help your already rising arrest record for drug related crime in Shelby…

  • The National Methadone Conference

    ByAdmin
    Admin 03/14/2023

    Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session  NAMA offers special thanks to Mallinckrodt. We also wish to thank Haworth Press, Vista Pharmaceuticals, Bendiner Labs, NIDA, and CSAT without whose support the first Certified Methadone Advocate (CMA) Training Course would not…

  • Publication Index-1

    ByAdmin
    Admin 09/22/2021

    Changes in Methadone Treatment Practices: Results From a National Panel Study, 1988-2000 by Thomas D’Aunno, PhD; Harold A. Pollack, PhD Journal of the American Medical Association Vol. 288, No. 7 August 21, 2002 Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use…